IN2012DN00390A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN00390A IN2012DN00390A IN390DEN2012A IN2012DN00390A IN 2012DN00390 A IN2012DN00390 A IN 2012DN00390A IN 390DEN2012 A IN390DEN2012 A IN 390DEN2012A IN 2012DN00390 A IN2012DN00390 A IN 2012DN00390A
- Authority
- IN
- India
- Prior art keywords
- bone
- alleviation
- maybe
- loosening
- stimulation
- Prior art date
Links
- 208000006386 Bone Resorption Diseases 0.000 abstract 1
- 206010065687 Bone loss Diseases 0.000 abstract 1
- 208000029725 Metabolic bone disease Diseases 0.000 abstract 1
- 230000024279 bone resorption Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000004069 differentiation Effects 0.000 abstract 1
- 210000002997 osteoclast Anatomy 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
- 0 CC(C)CC(*(C)=O)NC(C)* Chemical compound CC(C)CC(*(C)=O)NC(C)* 0.000 description 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06052—Val-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
- C07K5/06095—Arg-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0900834 | 2009-06-18 | ||
| US22000609P | 2009-06-24 | 2009-06-24 | |
| PCT/SE2010/050682 WO2010147547A1 (fr) | 2009-06-18 | 2010-06-17 | Nouveaux dérivés de peptide pour le traitement, la prévention ou l'atténuation d'une affection associée à une perte osseuse ou une densité osseuse faible ou inhiber la différenciation et la stimulation d'ostéoclastes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN00390A true IN2012DN00390A (fr) | 2015-08-21 |
Family
ID=43356620
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN390DEN2012 IN2012DN00390A (fr) | 2009-06-18 | 2010-06-17 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US8748370B2 (fr) |
| EP (1) | EP2443136A4 (fr) |
| IN (1) | IN2012DN00390A (fr) |
| WO (1) | WO2010147547A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010147547A1 (fr) * | 2009-06-18 | 2010-12-23 | Neobiotics Ab | Nouveaux dérivés de peptide pour le traitement, la prévention ou l'atténuation d'une affection associée à une perte osseuse ou une densité osseuse faible ou inhiber la différenciation et la stimulation d'ostéoclastes |
| KR101510743B1 (ko) * | 2013-07-23 | 2015-04-10 | (주)케어젠 | 파골 세포 분화 억제용 펩타이드 및 이의 용도 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0504938A3 (en) * | 1991-03-22 | 1993-04-14 | Suntory Limited | Prophylactic and therapeutic agent for bone diseases comprising di- or tripeptide derivative as active ingredient |
| US6015790A (en) * | 1997-10-06 | 2000-01-18 | Basf Aktiengesellschaft | Methods and compositions for treating rheumatoid arthritis |
| AU2583901A (en) | 1999-12-17 | 2001-06-25 | Ariad Pharmaceuticals, Inc. | Proton pump inhibitors |
| AU2001265092A1 (en) | 2000-06-02 | 2001-12-17 | Regents Of The University Of California | Profiling of protease specificity using combinatorial fluorogenic substrate libraries |
| BR0111718A (pt) * | 2000-06-16 | 2003-09-09 | Hercules Inc | Peptìdeos quimicamente modificados, composições e métodos de produção e uso |
| WO2006052201A1 (fr) | 2004-11-10 | 2006-05-18 | Neobiotics Ab | Utilisation de derives de dipeptides pour la fabrication d'un medicament destine au traitement d'infections microbiennes |
| EP2019819A4 (fr) * | 2006-05-09 | 2011-01-19 | Neobiotics Ab | Derives peptidiques innovants utilisables en tant agents antimicrobiens pour le traitement des blessures |
| WO2010147547A1 (fr) * | 2009-06-18 | 2010-12-23 | Neobiotics Ab | Nouveaux dérivés de peptide pour le traitement, la prévention ou l'atténuation d'une affection associée à une perte osseuse ou une densité osseuse faible ou inhiber la différenciation et la stimulation d'ostéoclastes |
-
2010
- 2010-06-17 WO PCT/SE2010/050682 patent/WO2010147547A1/fr not_active Ceased
- 2010-06-17 IN IN390DEN2012 patent/IN2012DN00390A/en unknown
- 2010-06-17 US US13/379,146 patent/US8748370B2/en not_active Expired - Fee Related
- 2010-06-17 EP EP10789825A patent/EP2443136A4/fr not_active Withdrawn
-
2014
- 2014-04-21 US US14/257,255 patent/US9169289B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20120108515A1 (en) | 2012-05-03 |
| US20140243274A1 (en) | 2014-08-28 |
| EP2443136A4 (fr) | 2013-01-09 |
| EP2443136A1 (fr) | 2012-04-25 |
| WO2010147547A1 (fr) | 2010-12-23 |
| US9169289B2 (en) | 2015-10-27 |
| US8748370B2 (en) | 2014-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2470257A4 (fr) | Implants osseux pour le traitement d'une infection | |
| MY165579A (en) | Synthetic methods for spiro-oxindole compounds | |
| IL240966A (en) | Orthopedic implants are tailored to the patient | |
| MX2011007930A (es) | Conjugados de insulina cristalina. | |
| MX2012009748A (es) | USO DE PEPTIDOS INHIBIDORES DEL FACTOR DE CRECIMIENTO TRANSFORMANTE-BETA1(TGF-ß1) PARA EL TRATAMIENTO DE FIBROSIS Y/U OPACIDAD CORNEAL. | |
| IN2014DN08676A (fr) | ||
| HK1221171A1 (zh) | 用於刺激骨生长的组合物 | |
| IN2012DN00624A (fr) | ||
| WO2011039502A3 (fr) | Implant chirurgical | |
| ZA201303529B (en) | Implantable device for preventive or curative treatment of fractures of the femur, associated ancillary device | |
| GB2497899B (en) | Sanguiin for use in the prevention or treatment of bone marrow inhibition | |
| WO2010090767A3 (fr) | Amélioration de la biocompatibilité d'un dispositif médical | |
| WO2011147034A8 (fr) | Composés conjugués prostaglandine-bisphosphonate, leurs méthodes de fabrication et leurs utilisations | |
| EP2134300A4 (fr) | Ciments au phosphate de calcium comprenant un os autologue | |
| MX2012002299A (es) | Uso de cetoenoles ciclicos contra bacterias fitopatogenas. | |
| PT3785739T (pt) | Partículas de fosfato de cálcio vítreo, revestimentos e materiais de enxerto ósseo relacionados | |
| IN2012DN00390A (fr) | ||
| GB2504372B (en) | Surgical orthopedic implants made from wear-resistant cobalt-chromium-molybdenum alloys | |
| MY177020A (en) | Compositions and methods for maintaining bone heal th or reducing bone loss | |
| WO2011132871A3 (fr) | Organe d'élévation de membrane sous-antrale et son procédé de fabrication | |
| SG10201408187XA (en) | Treatment of Bone Fracture | |
| PT2490667T (pt) | Composição compreendendo solanum glaucophyllum para prevenir e/ou tratar a hipocalcemia e para estabilizar os níveis de cálcio no sangue | |
| SG10201403562UA (en) | Implant for the treatment or prevention of an aneurysm | |
| WO2011084898A3 (fr) | Amélioration de la cicatrisation osseuse | |
| EP2459507A4 (fr) | Utilisation d érythritol pour la prévention ou le traitement de l hypertension |